tirzepatide diabetic retinopathy risk The popular #diabetes and weight loss medication #tirzepatide (brand name Mounjaro or Zepbound) may lower the of #retinopathy, a leading cause of vision loss, according to Dr. Szilárd Kiss and Molecular mechanisms underpinning tirzepatide activity

In December 2023, Eli Lilly and Company, one of the major GLP-1 receptor agonist companies, announced the availability of Zepbound (tirzepatide) injection, a GLP-1 drug, in the U.S

(2015) The retinoblastoma (Rb) protein regulates ferroptosis induced by sorafenib in human hepatocellular carcinoma cells, Cancer Lett

In practice, this means: Having more frequent blood pressure checks in the first 3 months Possibly monitoring your blood pressure at home Reporting any dizziness or lightheadedness promptly to your doctor Being prepared for potential adjustments to your existing medications Never adjust your blood pressure medications yourself without consulting your healthcare provider

A moderate low-carb approach (50 to 100 grams of carbohydrates per day) provides many of the metabolic benefits with fewer side effects and may be the better individual choice